Skip to main content
. 2017 Apr 19;8(27):44073–44081. doi: 10.18632/oncotarget.17237

Table 3. Adverse events.

Event Any grade Grade 3-4
No of Patients % No of Patients %
Cardio-renal
 Atrial fibrillation 1 6%
 Elevated creatinine 5 28% 1 6%
 Elevated phosphate 2 11%
 Elevated glucose 3 17%
 Hypoalbuminemia 2 11%
 Hypokalemia 3 17% 1 6%
 Hypomagnesemia 3 17%
 Hyponatremia 2 11% 1 6%
 Hypophosphatemia 2 11% 1 6%
Constitutional
 Dehydration 1 6%
 Fatigue 8 44% 1 6%
Dermatologic
 Alopecia 3 17%
Gastrointestinal
 Anorexia 3 17%
 Hematemesis 2 11% 1 6%
 Hiccups 1 6% 1 6%
 Diarrhea 1 6%
 Elevated liver function tests 4 22% 1 6%
 Hematochezia 1 6%
 Nausea or vomiting 12 67% 1 6%
HEENT
 Epistaxis 2 11% 2 11%
Hematologic
 Anemia 14 78% 4 22%
 Elevated PT/PTT 4 22% 4 22%
 Bleeding or bruising 1 6%
 Lymphopenia 15 83% 13 72%
 Myelodysplastic Syndrome 2 11% 2 11%
 Neutropenia 16 89% 16 89%
 Thrombocytopenia 12 67% 1 6%
Infectious
 Sepsis 1 6%
 Febrile neutropenia 4 22% 4 22%
 Fever 2 11%
Neurologic
 Subdural hematoma 1 6% 1 6%